Optiver Holding
IBB icon

Optiver Holding’s iShares Biotechnology ETF IBB Stock Holding History

Optiver Holding’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-941
Closed -$159K – 2916
2026
Q1 		$159K Buy
+941
New +$161K ﹤0.01% 840
2022
Q2 		– Sell
-347
Closed -$45K – 431
2022
Q1 		$45K Sell
347
-149
-30% -$19.4K ﹤0.01% 302
2021
Q4 		$76K Buy
+496
New +$76.8K ﹤0.01% 338

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Optiver Holding's IBB Position: Q2 2026 in Review

Optiver Holding sold out of iShares Biotechnology ETF (IBB) in Q2 2026, closing a stake of 941 shares — an estimated $159K sold.

Optiver Holding first reported a position in IBB in Q4 2021 and held it in 3 quarters. The position peaked at $159K in Q1 2026. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Optiver Holding reported no remaining iShares Biotechnology ETF position as of Q2 2026 after selling out during the quarter.
  • Optiver Holding sold 941 iShares Biotechnology ETF shares in Q2 2026, an estimated $159K.
  • Optiver Holding first reported a position in iShares Biotechnology ETF in Q4 2021 and held it in 3 quarters.
  • Optiver Holding's iShares Biotechnology ETF position peaked at $159K in Q1 2026.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.